Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Roivant Sciences (ROIV) Receivables - Accured: 2023-2024

Historic Receivables - Accured for Roivant Sciences (ROIV) over the last 2 years, with Dec 2024 value amounting to $23.2 million.

  • Roivant Sciences' Receivables - Accured rose 22.68% to $23.2 million in Q4 2024 from the same period last year, while for Dec 2024 it was $23.2 million, marking a year-over-year increase of 22.68%. This contributed to the annual value of $23.2 million for FY2024, which is 22.68% up from last year.
  • Per Roivant Sciences' latest filing, its Receivables - Accured stood at $23.2 million for FY2024, which was down 15.50% from $27.4 million recorded in FY2024.
  • In the past 5 years, Roivant Sciences' Receivables - Accured registered a high of $27.4 million during FY2024, and its lowest value of $4.9 million during FY2023.
  • Over the past 2 years, Roivant Sciences' median Receivables - Accured value was $21.0 million (recorded in 2023), while the average stood at $18.6 million.
  • Data for Roivant Sciences' Receivables - Accured shows a peak YoY skyrocketed of 458.99% (in 2024) over the last 5 years.
  • Roivant Sciences' Receivables - Accured (Yearly) stood at $4.9 million in 2023, then reached $18.9 million in 2023, then soared by 458.99% to $27.4 million in 2024, then grew by 22.68% to $23.2 million in 2024.